Cargando…

Increased expression of urotensin II is associated with poor prognosis in hepatocellular carcinoma

Urotensin II (UII) and the urotensin II receptor (UT) exhibit mitogenic effects on tumor growth. Our previous study demonstrated that the UII/UT system is upregulated in hepatocellular carcinoma (HCC) and may enhance the proliferation of human hepatoma cells. However, the clinical significance of UI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Dian-Gang, Chen, Jing, Wang, Hong-Xia, Li, Bao-Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228350/ https://www.ncbi.nlm.nih.gov/pubmed/28105202 http://dx.doi.org/10.3892/ol.2016.5344

Ejemplares similares

Urotensin II receptor as a potential biomarker for the prognosis of hepatocellular carcinoma patients
por: Wei, Hongtao, et al.
Publicado: (2017)

Expression of urotensin II is associated with placental autophagy in patients with severe preeclampsia
por: Pan, Ya-Jing, et al.
Publicado: (2018)

Urotensin II in cardiovascular regulation
por: Russell, Fraser D
Publicado: (2008)

Central and Peripheral Effects of Urotensin II and Urotensin II-Related Peptides on Cardiac Baroreflex Sensitivity in Trout
por: Lancien, Frédéric, et al.
Publicado: (2017)

Urotensin II promotes aldosterone expression in rat aortic adventitial fibroblasts
por: Li, Jun, et al.
Publicado: (2018)

Human U Three Protein 14a Expression is Increased in Hepatocellular Carcinoma and Associated with Poor Prognosis
por: Zhang, Jing-Yi, et al.
Publicado: (2017)

Increased Expression of CAP2 Indicates Poor Prognosis in Hepatocellular Carcinoma()()
por: Fu, Jia, et al.
Publicado: (2015)

Sperm-Associated Antigen 5 Expression Is Increased in Hepatocellular Carcinoma and Indicates Poor Prognosis
por: Zhou, Hua, et al.
Publicado: (2018)

Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma
por: Wang, Ying, et al.
Publicado: (2015)

Inhibitory Effect of an Urotensin II Receptor Antagonist on Proinflammatory Activation Induced by Urotensin II in Human Vascular Endothelial Cells
por: Park, Sung Lyea, et al.
Publicado: (2013)

Divergent cardio-ventilatory and locomotor effects of centrally and peripherally administered urotensin II and urotensin II-related peptides in trout
por: Vanegas, Gilmer, et al.
Publicado: (2015)

Galectin-9 expression predicts poor prognosis in hepatitis B virus-associated hepatocellular carcinoma
por: Jiao, Jianhua, et al.
Publicado: (2022)

Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion
por: Franco, Renato, et al.
Publicado: (2014)

An investigation into the expression and mechanism of action of urotensin II in chronic pressure-overloaded rat hearts
por: LIU, WENYUAN, et al.
Publicado: (2015)

Irisin levels are associated with urotensin II levels in diabetic patients
por: He, Wan-Yu, et al.
Publicado: (2015)

Zinc finger protein ZBTB20 expression is increased in hepatocellular carcinoma and associated with poor prognosis
por: Wang, Qing, et al.
Publicado: (2011)

Increased mediator complex subunit 15 expression is associated with poor prognosis in hepatocellular carcinoma
por: Wang, Kunyuan, et al.
Publicado: (2018)

ROCK2 Polymorphism and Expression Contribute to Increased Susceptibility and Poor Prognosis in Hepatocellular Carcinoma
por: Qin, Lifeng, et al.
Publicado: (2022)

Numb Promotes Cell Proliferation and Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Wu, Jian, et al.
Publicado: (2014)

High Expression of FLOT1 Is Associated with Progression and Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Shi-Hong, et al.
Publicado: (2013)

Increased expression of PDIA3 and its association with cancer cell proliferation and poor prognosis in hepatocellular carcinoma
por: Takata, Hideyuki, et al.
Publicado: (2016)

Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

Expression of Prostate-Specific Membrane Antigen in Tumor-Associated Vasculature Predicts Poor Prognosis in Hepatocellular Carcinoma
por: Jiao, Dian, et al.
Publicado: (2019)

Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma
por: Fu, Shun-Jun, et al.
Publicado: (2018)

Urotensin II in Invertebrates: From Structure to Function in Aplysia californica
por: Romanova, Elena V., et al.
Publicado: (2012)

Increased fibrillarin expression is associated with tumor progression and an unfavorable prognosis in hepatocellular carcinoma
por: Zhang, Jing, et al.
Publicado: (2021)

Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis
por: Kim, Jongmin, et al.
Publicado: (2009)

Potential Clinical Implications of the Urotensin II Receptor Antagonists
por: Tsoukas, Philip, et al.
Publicado: (2011)

Urotensin II Promotes Atherosclerosis in Cholesterol-Fed Rabbits
por: Li, Yafeng, et al.
Publicado: (2014)

Urotensin-II: More Than a Mediator for Kidney
por: Balat, Ayşe, et al.
Publicado: (2012)

Blockade of Urotensin II Receptor Prevents Vascular Dysfunction
por: Kim, Young-Ae, et al.
Publicado: (2016)

Role of Urotensin-II in Saphenous Vein Graft Disease
por: Tüysüz, Mehmet Erin, et al.
Publicado: (2020)

Urotensin II levels in patients with inflammatory bowel disease
por: Alicic, Damir, et al.
Publicado: (2021)

Correction: Numb Promotes Cell Proliferation and Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Wu, Jian, et al.
Publicado: (2022)

The urotensin II receptor antagonist, urantide, protects against atherosclerosis in rats
por: ZHAO, JUAN, et al.
Publicado: (2013)

Decreased DC-SIGNR expression in hepatocellular carcinoma predicts poor patient prognosis
por: Xia, Hai-Bing, et al.
Publicado: (2020)

Increased expression of insulin-like growth factor-1 receptor predicts poor prognosis in patients with hepatocellular carcinoma
por: Zhang, Zhiquan, et al.
Publicado: (2019)

Downregulation of PDK4 Increases Lipogenesis and Associates with Poor Prognosis in Hepatocellular Carcinoma
por: Yang, Chen, et al.
Publicado: (2019)

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma
por: Jiang, Shan-Shan, et al.
Publicado: (2014)

Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_q49sg2khg6meup46iqis2suoec